載入...
Reversing the Deleterious Effects of α2-antiplasmin on Tissue Plasminogen Activator Therapy Improves Outcomes in Experimental Ischemic Stroke
High blood levels of α2-antiplasmin have been associated with failed tissue plasminogen activator (TPA) therapy for ischemic stroke. Yet, other data suggests that α2-antiplasmin may be protective in stroke, because it defends against bleeding and excitotoxicity. To address this paradox, we examined...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4066326/ https://ncbi.nlm.nih.gov/pubmed/24556477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2014.02.009 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|